Atlas Trials

Study of Oral High/Low-dose Cepharanthine Compared With Placebo in Non Hospitalized Adults With COVID-19

Clinical trial NCT05398705 · COMPLETED

Trial details

NCT number
NCT05398705
Sponsor
Shanghai Jiao Tong University School of Medicine
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Asymptomatic COVID-19
Start date
2022-05-31
Primary completion
2022-08-10
Enrollment
450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.